Abbisko Therapeutics Co., Ltd

No.3, 898 Lane, Halei Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, China

Clinical Trials

8 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

71.8%

Phase 2

23.1%

Phase 3

2.6%

Trial Status Distribution

Active, not recruiting

7.7%

Completed

30.8%

Enrolling By Invitation

5.1%

Not yet recruiting

7.7%

Recruiting

41.0%

Unknown

7.7%

Clinical Trials

Trials sponsored by this organization (39)

A Phase 2 Study of ABSK043 Combined With Osimertinib

Phase 2

Not yet recruiting

interventional

Aug 202672 participants

A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration

Phase 1

Recruiting

interventional

Aug 2026247 participants

A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole Enteric-Coated Tablets on the Pharmacokinetics of ABSK-011 Capsules in Healthy Participants

Phase 1

Recruiting

interventional

Jul 202630 participants

A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )

Phase 1

Recruiting

interventional

Mar 2026401 participants

A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia

Phase 1

Not yet recruiting

interventional

Dec 2025110 participants

A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib

Phase 2

Recruiting

interventional

Sep 202586 participants

A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Proportions in Healthy Subjects

Phase 1

Completed

interventional

Sep 202520 participants

A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors

Phase 1

Recruiting

interventional

Jul 2025266 participants

Page 1 of 5

Approvals

No approval data available

News

No news articles found

Back to Organizations